Revenue | ₹1.36Cr |
Net Profits | ₹0.78Cr |
Net Profit Margins | 57.35% |
Venmax Drugs & Pharmaceuticals Ltd’s revenue jumped 1260% since last year same period to ₹1.36Cr in the Q4 2024-2025. On a quarterly growth basis, Venmax Drugs & Pharmaceuticals Ltd has generated 580% jump in its revenue since last 3-months.
Venmax Drugs & Pharmaceuticals Ltd’s net profit jumped 1460% since last year same period to ₹0.78Cr in the Q4 2024-2025. On a quarterly growth basis, Venmax Drugs & Pharmaceuticals Ltd has generated 256% jump in its net profits since last 3-months.
Venmax Drugs & Pharmaceuticals Ltd’s net profit margin jumped 14.71% since last year same period to 57.35% in the Q4 2024-2025. On a quarterly growth basis, Venmax Drugs & Pharmaceuticals Ltd has generated 122.94% jumped in its net profit margins since last 3-months.
The revenue for Venmax Drugs & Pharmaceuticals Ltd in the Q4 results 2024 was ₹1.36Cr.
The net profit for Venmax Drugs & Pharmaceuticals Ltd in the Q4 results 2024 was ₹0.78Cr.
The net profit margin for Venmax Drugs & Pharmaceuticals Ltd in the Q4 results 2024 was 57.35%.
The revenue for Venmax Drugs & Pharmaceuticals Ltd in the Q4 results 2023 was ₹0.10Cr.
The net profit for Venmax Drugs & Pharmaceuticals Ltd in the Q4 results 2023 was ₹0.05Cr.
The net profit margin for Venmax Drugs & Pharmaceuticals Ltd in the Q4 results 2023 was 50.00%.